Scotia Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
Scotia Capital's ZBH Position: Q3 2026 in Review
Scotia Capital reduced its Zimmer Biomet (ZBH) stake by 20% in Q3 2026, selling an estimated $74.8K and leaving 3,162 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #837.
Scotia Capital first reported a position in ZBH in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.88M in Q4 2022. 933 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.
- Scotia Capital held 3,162 shares of Zimmer Biomet worth $281K as of Q3 2026.
- Scotia Capital sold 790 Zimmer Biomet shares in Q3 2026, an estimated $74.8K.
- Zimmer Biomet made up ﹤0.01% of Scotia Capital's portfolio in Q3 2026, its #837 holding.
- Scotia Capital first reported a position in Zimmer Biomet in Q3 2020 and has held it in 17 quarters since.
- Scotia Capital's Zimmer Biomet position peaked at $1.88M in Q4 2022.
- 933 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.
Based on Scotia Capital's 13F filing for Q3 2026, filed 10 Nov 2026.